BREWIN DOLPHIN LTD - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 217 filers reported holding IMMUNOMEDICS INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.6%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$170,060
+79.7%
2,000
-25.1%
0.01%
+57.1%
Q2 2020$94,625
+162.9%
2,6700.0%0.01%
+75.0%
Q1 2020$35,992
-49.1%
2,670
-20.1%
0.00%
-33.3%
Q4 2019$70,674
-41.9%
3,340
-63.6%
0.01%
-50.0%
Q3 2019$121,594
-4.4%
9,1700.0%0.01%
-7.7%
Q2 2019$127,188
-27.8%
9,1700.0%0.01%
-31.6%
Q1 2019$176,156
-7.3%
9,170
-31.2%
0.02%
-24.0%
Q4 2018$190,076
+45.4%
13,320
+112.3%
0.02%
+66.7%
Q3 2018$130,687
+3795.3%
6,274
+2514.2%
0.02%
Q3 2017$3,3552400.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 4,750,000$112,433,00020.02%
Avoro Capital Advisors LLC 17,714,461$419,301,00016.14%
Foresite Capital Management III, LLC 2,541,729$60,163,00012.96%
Foresite Capital Management IV, LLC 1,231,543$29,151,0009.94%
Ghost Tree Capital, LLC 1,250,000$29,588,0008.71%
NEXTHERA CAPITAL LP 1,329,104$31,460,0004.87%
RA Capital Management 3,119,778$73,845,0004.79%
DLD Asset Management, LP 2,682,100$63,458,0004.78%
Palo Alto Investors LP 4,803,364$113,696,0004.54%
DLD Asset Management, LP 2,411,600$57,058,0004.30%
View complete list of IMMUNOMEDICS INC shareholders